tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:MOL0 Stock Latest News

Moleculin Biotech announces enrollment milestone in MIRACLE trial
The FlyMoleculin Biotech announces enrollment milestone in MIRACLE trial
13h ago
MBRX
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
PremiumCompany Announcements
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
14h ago
8K
MBRX
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
PremiumRatings
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
3d ago
MBRX
Moleculin Biotech Updates Investors with New Corporate Presentation
PremiumCompany Announcements
Moleculin Biotech Updates Investors with New Corporate Presentation
5d ago
8K
MBRX
Moleculin Biotech reports FY25 EPS ($28.42) vs. ($189.14) last year
PremiumThe Fly
Moleculin Biotech reports FY25 EPS ($28.42) vs. ($189.14) last year
5d ago
MBRX
Moleculin Biotech sees cash runway into 3Q26
PremiumThe FlyMoleculin Biotech sees cash runway into 3Q26
5d ago
MBRX
MBRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MBRX Earnings this Week: How Will it Perform?
6d ago
MBRX
Moleculin Biotech Raises Capital via Inducement Warrant Agreements
Premium
Company Announcements
Moleculin Biotech Raises Capital via Inducement Warrant Agreements
1M ago
8K
MBRX
Early Efficacy Signal in Annamycin’s Phase 3 MIRACLE Trial Supports Buy Rating on Moleculin
PremiumRatings
Early Efficacy Signal in Annamycin’s Phase 3 MIRACLE Trial Supports Buy Rating on Moleculin
1M ago
MBRX
Moleculin Biotech announces exercise of warrants for $8.3M gross proceeds
PremiumThe Fly
Moleculin Biotech announces exercise of warrants for $8.3M gross proceeds
1M ago
MBRX
Moleculin Biotech Issues New Investor Corporate Presentation
PremiumCompany Announcements
Moleculin Biotech Issues New Investor Corporate Presentation
1M ago
8K
MBRX
Moleculin Reports Positive Progress in MIRACLE AML Trial
PremiumCompany Announcements
Moleculin Reports Positive Progress in MIRACLE AML Trial
1M ago
8K
MBRX
Moleculin approach first unblinding of data from Phase 2B/3 study of Annamycin
PremiumThe FlyMoleculin approach first unblinding of data from Phase 2B/3 study of Annamycin
1M ago
MBRX
Moleculin Biotech announces notice of allowance for JPO covering Annamycin
Premium
The Fly
Moleculin Biotech announces notice of allowance for JPO covering Annamycin
1M ago
MBRX
Moleculin Gains Japanese Patent Allowance for Annamycin
Premium
Company Announcements
Moleculin Gains Japanese Patent Allowance for Annamycin
1M ago
8K
MBRX
Moleculin Biotech announces launch of CEO Corner platform
PremiumThe Fly
Moleculin Biotech announces launch of CEO Corner platform
1M ago
MBRX
Moleculin Biotech Shareholders Approve Warrant Share Issuance
PremiumCompany Announcements
Moleculin Biotech Shareholders Approve Warrant Share Issuance
2M ago
8K
MBRX
Moleculin Biotech Updates Investors with New Corporate Presentation
PremiumCompany Announcements
Moleculin Biotech Updates Investors with New Corporate Presentation
2M ago
8K
MBRX
De‑Risked Safety and Pivotal 2026 Catalyst Underpin Buy Rating on Moleculin’s Annamycin Oncology Franchise
PremiumRatings
De‑Risked Safety and Pivotal 2026 Catalyst Underpin Buy Rating on Moleculin’s Annamycin Oncology Franchise
2M ago
MBRX
Moleculin Highlights Non-Cardiotoxic Profile of Lead Annamycin Drug
PremiumCompany AnnouncementsMoleculin Highlights Non-Cardiotoxic Profile of Lead Annamycin Drug
2M ago
8K
MBRX
Moleculin Biotech reports assessment confirms no cardiotoxicity of Annamycin
Premium
The Fly
Moleculin Biotech reports assessment confirms no cardiotoxicity of Annamycin
2M ago
MBRX
Moleculin Biotech advances Annamycin AML Phase 3 program
Premium
Company Announcements
Moleculin Biotech advances Annamycin AML Phase 3 program
2M ago
8K
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >